BD Expands Diagnostic Testing Offerings in Women’s Health

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced Monday it has received clearance from the U.S. Food and Drug Administration to utilize its BD ProbeTec Chlamydia trachomatis Qx and BD ProbeTec Neisseria gonorrhoeae Qx Amplified DNA Assays with samples collected during women’s routine liquid-based Pap testing for cervical cancer screening.
MSN